Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 186
- Press releases
NHS Reimburses The Cost Of Cannabis Treatment To The First Zerenia Clinics UK Patient
PRESS RELEASE KHIRON Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), continues to spearhead the medical cannabis market in the United Kingdom by successfully attaining, for the first time, full reimbursement by the NHS of costs associated to cannabis-based medication and clinic fees for a patient enrolled in Zerenia™ Clinics UK.
- Companies
Celadon granted MHRA GMP certification for cannabis API
The UK-based pharmaceutical company has stated that the registration follows seven harvests and extractions and an MHRA inspection in 2022.
- Uncategorized
Google erwärmt sich für CBD, Kardashian’s deutsche Ambitionen, UN lockert ihre Haltung zu Drogen, Prohibitionisten schmollen, Londoner Firma will sich in “Oz” listen lassen
GOOGLE hat seine Werberichtlinien in begrenztem Umfang geändert, um in drei Ländern – Kalifornien, Colorado und Puerto Rico – die Werbung für CBD-Präparate auf seinen Plattformen zuzulassen.
- CBD Market
Google Warms To CBD, Kardashian’s German Ambitions, UN Softens Drugs Stance, Prohibitionists Pout, London Firm Looks To List in ‘Oz’
GOOGLE has made limited changes to its advertising policies to allow CBD topicals to be promoted on its platforms in three jurisdictions – California, Colorado, and Puerto Rico.
- CBD Market
Study shows less risk of harm by alcohol in states with legal cannabis
TWIN STUDY Study shows less risk of harm by alcohol in states with legal cannabis Marijuana Moment reports that researchers have found that those living in states where cannabis had been legalised were “less likely to risk harm while under the influence of alcohol” than their twin residing in a state where cannabis remained prohibited.
- Markets & Stocks
European Cannabis Stocks Review: Khiron Spikes On Colombian Insurance Deal, Apollon Divests Patents, & More From Seach Medical
Khiron Life Sciences INTERNATIONAL medical cannabis company Khiron has seen its share price skyrocket over 60% following a crucial resolution that was passed by the Colombian Ministry of Health.
- CBD Market
Canopy Growth looking at the US market due to the increased competition in Canadian adult-use market
CANOPY GROWTH Canopy Growth looking at the US market due to the increased competition in Canadian adult-use market The Motley Fool reports that Canopy’s sales in the second quarter of fiscal 2023 were reported as CAD$118 million, down 10% year over year.
- Companies
Apollon Formularies and Global Hemp Group sign Letter of Intent
UK-based Apollon Formularies and Global Hemp Group (GHG) have signed a Letter of Intent GHG will acquire the exclusive perpetual license for North America to certain Apollon Intellectual Property and proprietary technology.
- Medical
Italian Army Pledges To More Than Double Medical Cannabis Production This Year, But Supply Issues Far From Over
THE Italian army, which continues to hold a monopoly over medical cannabis production, has announced plans to dramatically ramp up production this year.
- Adult-Use
Arizona’s adult use sales are up as medical sales fall
NEW HIGHS Arizona’s adult use sales are up as medical sales fall Benzinga reports that Arizona’s adult-use cannabis sales reached a new high in October 2022, with more than USD$85.4 million in estimated sales, $5 million above the $80.4 million from September sales.
- CBD Market
UK company granted ethics approval for CBD trial
The company has received Ethics Approval from Bellberry Human Research Ethics Committee in Australia.
- Medical
Spain Misses Ambitious Medical Cannabis Roll Out Targets As Government Remains Tight-Lipped On Progress
SPAIN’s ambitious plans to see the regulation and distribution of medical cannabis rolled out across the country by the end of 2022 appear to have been delayed.
